DRKS00025056
Completed
Phase 4
Treatment of wound healing disorders in patients with diabetic foot syndrome caused by diabetic neuropathy (neuropathic foot), or diabetic angiopathy (gangrene) with the medical device TOXAPREVENT SKIN® skin powder and early detection of a possible wound infection by MEANS of VOC analysis by MCC-IMS - MANC-MCC-IMS-202005
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- E14.7
- Sponsor
- FROXIMUN AG
- Enrollment
- 50
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Indication according to the target
- •Healthy skin areas present as a control area
- •Patients with diabetic neuropathy (neuropathic foot), or diabetic angiopathy (gangrene)
Exclusion Criteria
- •Severe HKE (cardiovascular disease)
- •other primarily chronic skin diseases
- •Higher degree of liver and/or renal failure
- •higher\-grade dementia/ Delir
- •Septic disease
- •Lack of compliance
- •Lack of consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical and Radiologic Evaluation of Wound Healing After Extraction of Impacted Third Molars in Hypothyroid PatientsTCTR20240802005Akdeniz University, Dentistry Faculty40
Not yet recruiting
Phase 2
Management of wound by an ayurvedic ointment.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2024/07/070969Shri BMK AMV
Not yet recruiting
Phase 3
The effect of probiotic on wound healing.IRCT20130514013321N2Shiraz University of Medical Sciences90
Active, not recruiting
Not Applicable
healing wounds evaluation in patients with sickle cell anemiaSickle cell Disease, Leg ulcerC15.378.071.141.150.150C17.800.893.592RBR-2x96t2niversidade Federal de Sergipe
Active, not recruiting
Not Applicable
Comparison of wound treatment and wound healing with a hyaluronic acid-containing matrix vs. hydrofibre and skin transplant healing rates for defect coverage after resection of skin tumorsC43C44Malignant melanoma of skinOther malignant neoplasms of skinDRKS00006293ATG-Med, AT Technologies GmbH29